Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment: a two-part clinical study. Part A: Multisite MRI Acquisition - Protocol Harmonization Part B: Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment: a clinical study
Completed
- Conditions
- 10042258Mild Cognitive Impairmentobjective memory impairment without dementia
- Registration Number
- NL-OMON38870
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 15
Inclusion Criteria
Patients with a diagnosis of Mild Cognitive Impairment, aged 55-90 years and memory complaints verified by a physician and on cognitive testing.
Exclusion Criteria
Ischaemic lesions
Head injury with loss of consciousness > 24 hours
Current substance abuse or therapy with steroids or chemotherapy
Systemic disease with frequent involvement of the CNS
CNS disease diagnosed or in treatment
Inadequate for neuropsychological testing
Enrolment in other trials/studies not compatible with this study
Use of specific medication
(History of) neurological/psychiatric illnesses
Ferromagnetic implants and devices not eligible for MRI scanning
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method